SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer (CEO), effective January 27, 2024, and will also be appointed to the Company’s Board of Directors. SIGA’s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024.
Related news for (SIGA)
- Calidi Biotherapeutics Advancing RTNova in Collaboration with SIGA Technologies
- SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
- SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results
- SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox